Pfizer administers COVID-19 vaccines to infants, kids in new trial
March 26 2021, 08:00
The first participants aged six months to 11 years have been administered Pfizer’s COVID-19 vaccine as part of a global trial assessing safety and tolerability in younger age groups, the company announced Thursday.
The first participants aged six months to 11 years have been administered Pfizer’s COVID-19 vaccine as part of a global trial assessing safety and tolerability in younger age groups, the company announced Thursday.
Source:
FOX News